FDA Clearance Tracker · P230040-S015
CorPASS System
Last checked: Nov 20, 2026Latest source record: Dec 19, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Dec 19, 2025
Approved
Time to decision
231 days
Received May 2, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P230040-S015
- Device name
- CorPASS System
- Applicant
- Endotronix, Inc.
- Applicant location
- Naperville, IL
- Received
- May 2, 2025
- Decided
- Dec 19, 2025
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P230040
Device type
- Device type
- System, hemodynamic, implantable (MOM)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
Approval for to modifications in the implanters labeling to remove the mandatory Sensor recalibrations every 3 years.
Source documents
Other decisions for Endotronix, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P230040 · Decided Jun 20, 2024 · 190 days after receipt
Device type: System, hemodynamic, implantable (MOM) · Cardiology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.